These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12925974)

  • 1. Increase in lobular breast cancer incidence in Switzerland.
    Levi F; Te VC; Randimbison L; La Vecchia C
    Int J Cancer; 2003 Oct; 107(1):164-5; author reply 166. PubMed ID: 12925974
    [No Abstract]   [Full Text] [Related]  

  • 2. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland.
    Verkooijen HM; Fioretta G; Vlastos G; Morabia A; Schubert H; Sappino AP; Pelte MF; Schäfer P; Kurtz J; Bouchardy C
    Int J Cancer; 2003 May; 104(6):778-81. PubMed ID: 12640687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is atypical lobular hyperplasia and what does it mean for the patient?
    Page DL; Simpson JF
    J Clin Oncol; 2005 Aug; 23(24):5432-3. PubMed ID: 16110003
    [No Abstract]   [Full Text] [Related]  

  • 4. Changing incidence rate of invasive lobular breast carcinoma among older women.
    Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
    Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
    Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
    J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive lobular carcinoma incidence increasing.
    CA Cancer J Clin; 2003; 53(3):137. PubMed ID: 12817609
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
    Aulmann S; Penzel R; Schirmacher P; Sinn HP
    Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related lobular involution and risk of breast cancer.
    Milanese TR; Hartmann LC; Sellers TA; Frost MH; Vierkant RA; Maloney SD; Pankratz VS; Degnim AC; Vachon CM; Reynolds CA; Thompson RA; Melton LJ; Goode EL; Visscher DW
    J Natl Cancer Inst; 2006 Nov; 98(22):1600-7. PubMed ID: 17105983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry.
    Saltzstein SL
    Anat Pathol; 1996; 1():193-203. PubMed ID: 9390929
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors affecting rise in the incidence of infiltrating lobular carcinoma of the breast.
    Chikman B; Lavy R; Davidson T; Wassermann I; Sandbank J; Siegelmann-Danieli N; Halevy A
    Isr Med Assoc J; 2010 Nov; 12(11):697-700. PubMed ID: 21243872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer statistics: Breast cancer in situ.
    Ward EM; DeSantis CE; Lin CC; Kramer JL; Jemal A; Kohler B; Brawley OW; Gansler T
    CA Cancer J Clin; 2015; 65(6):481-95. PubMed ID: 26431342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of age distribution patterns for different histopathologic types of breast carcinoma.
    Anderson WF; Pfeiffer RM; Dores GM; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1899-905. PubMed ID: 17035397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobular breast cancer: incidence and genetic and non-genetic risk factors.
    Dossus L; Benusiglio PR
    Breast Cancer Res; 2015 Mar; 17():37. PubMed ID: 25848941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
    Li CI; Daling JR; Malone KE
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms.
    Kravchenko J; Akushevich I; Seewaldt VL; Abernethy AP; Lyerly HK
    Breast Cancer Res Treat; 2011 Jul; 128(2):483-93. PubMed ID: 21225455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lobular carcinoma in situ of the breast].
    Llanos Muñoz M; Alonso Muñoz MC; Ojeda González B
    Med Clin (Barc); 1994 Oct; 103(14):553-6. PubMed ID: 7799670
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
    Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
    Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional variations in breast cancer incidence among California women, 1988-1997.
    Reynolds P; Hurley SE; Quach AT; Rosen H; Von Behren J; Hertz A; Smith D
    Cancer Causes Control; 2005 Mar; 16(2):139-50. PubMed ID: 15868455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction mammaplasty specimens and occult breast carcinomas.
    Kakagia D; Fragia K; Grekou A; Tsoutsos D
    Eur J Surg Oncol; 2005 Feb; 31(1):19-21. PubMed ID: 15642421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.